Mineralization of the Deep Gray Matter with Age: A Retrospective Review with Susceptibility-Weighted MR Imaging

References

1. ↵
   Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41–51

   PubMed
2. ↵
   Dobson J. Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Lett 2001;496:1–5

   CrossRefPubMedWeb of Science
3. ↵
   Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1–25

   CrossRefPubMedWeb of Science
4. ↵
   Koeppen AH. The history of iron in the brain. J Neurol Sci 1995;134 Suppl:1–9

   CrossRefPubMed
5. ↵
   Casanova MF, Araque JM. Mineralization of the basal ganglia: implications for neuropsychiatry, pathology and neuroimaging. Psychiatry Res 2003;121:59–87

   CrossRefPubMedWeb of Science
6. ↵
   Feekes JA, Cassell MD. The vascular supply of the functional compartments of the human striatum. Brain 2006;129:2189–201

   Abstract/FREE Full Text
7. ↵
   Yamada N, Imakita S, Sakuma T, et al. Intracranial calcification on gradient-echo phase image: depiction of diamagnetic susceptibility. Radiology 1996;198:171–78

   PubMedWeb of Science
8. ↵
   Cohen CR, Duchesneau PM, Weinstein MA. Calcification of the basal ganglia as visualized by computed tomography. Radiology 1980;134:97–99

   PubMedWeb of Science
9. ↵
   Vermersch P, Leys D, Pruvo JP, et al. Parkinson's disease and basal ganglia calcifications: prevalence and clinico-radiological correlations. Clin Neurol Neurosurg 1992;94:213–17

   CrossRefPubMed
10. ↵
    Aoki S, Okada Y, Nishimura K, et al. Normal deposition of brain iron in childhood and adolescence: MR imaging at 1.5 T. Radiology 1989;172:381–85

    PubMedWeb of Science
11. ↵
    Bartzokis G, Mintz J, Sultzer D, et al. In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol 1994;15:1129–38

    Abstract/FREE Full Text
12. Drayer BP. Imaging of the aging brain. Part II. Pathologic conditions. Radiology 1988;166:797–806

    PubMedWeb of Science
13. ↵
    Gelman N, Gorell JM, Barker PB, et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999;210:759–67

    PubMedWeb of Science
14. ↵
    Milton WJ, Atlas SW, Lexa FJ, et al. Deep gray matter hypointensity patterns with aging in healthy adults: MR imaging at 1.5 T. Radiology 1991;181:715–19

    PubMedWeb of Science
15. ↵
    Ketonen LM. Neuroimaging of the aging brain. Neurol Clin 1998;16:581–98

    CrossRefPubMedWeb of Science
16. ↵
    Chen JC, Hardy PA, Kucharczyk W, et al. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am J Neuroradiol 1993;14:275–81

    Abstract/FREE Full Text
17. ↵
    Drayer B, Burger P, Darwin R, et al. MRI of brain iron. AJR Am J Roentgenol 1986;147:103–10

    PubMedWeb of Science
18. ↵
    Ma J, Wehrli FW. Method for image-based measurement of the reversible and irreversible contribution to the transverse-relaxation rate. J Magn Reson B 1996;111:61–69

    CrossRefPubMed
19. ↵
    Reichenbach JR, Venkatesan R, Schillinger DJ, et al. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997;204:272–77

    PubMedWeb of Science
20. ↵
    Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612–18

    CrossRefPubMedWeb of Science
21. ↵
    Ogg RJ, Langston JW, Haacke EM, et al. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging 1999;17:1141–48

    CrossRefPubMedWeb of Science
22. ↵
    Cho ZH, Ro YM, Lim TH. NMR venography using the susceptibility effect produced by deoxyhemoglobin. Magn Reson Med 1992;28:25–38

    PubMedWeb of Science
23. ↵
    Lee BC, Vo KD, Kido DK, et al. MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. AJNR Am J Neuroradiol 1999;20:1239–42

    Abstract/FREE Full Text
24. ↵
    Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005;22:439–50

    CrossRefPubMed
25. ↵
    Tong KA, Ashwal S, Holshouser BA, et al. Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology 2003;227:332–39

    CrossRefPubMedWeb of Science
26. ↵
    Tong KA, Ashwal S, Holshouser BA, et al. Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann Neurol 2004;56:36–50

    CrossRefPubMedWeb of Science
27. ↵
    Rauscher A, Sedlacik J, Barth M, et al. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005;26:736–42

    Abstract/FREE Full Text
28. ↵
    Ifthikharuddin SF, Shrier DA, Numaguchi Y, et al. MR volumetric analysis of the human basal ganglia: normative data. Acad Radiol 2000;7:627–34

    CrossRefPubMedWeb of Science
29. ↵
    Steffens DC, McDonald WM, Tupler LA, et al. Magnetic resonance imaging changes in putamen nuclei iron content and distribution in normal subjects. Psychiatry Res 1996;68:55–61

    PubMedWeb of Science
30. ↵
    Schenck JF. Magnetic resonance imaging of brain iron. J Neurol Sci 2003;207:99–102

    CrossRefPubMedWeb of Science
31. ↵
    Schenker C, Meier D, Wichmann W, et al. Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen. Neuroradiology 1993;35:119–24

    CrossRefPubMedWeb of Science
32. ↵
    Steffens DC, Tupler LA, Ranga K, et al. Magnetic resonance imaging signal hypointensity and iron content of putamen nuclei in elderly depressed patients. Psychiatry Res 1998;83:95–103

    CrossRefPubMed
33. ↵
    Bartzokis G, Tishler TA, Lu PH, et al. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 2007;28:414–23

    CrossRefPubMedWeb of Science
34. ↵
    Collingwood JF, Mikhaylova A, Davidson M, et al. In situ characterization and mapping of iron compounds in Alzheimer's disease tissue. J Alzheimers Dis 2005;7:267–72

    PubMedWeb of Science